U.S. Court of Appeals for the Federal Circuit
Argentum Pharmaceuticals LLC v. Novartis Pharmaceuticals Corp.
This writing
- Type
- Opinion
- Filed
- April 23, 2020
- Case
- Argentum Pharmaceuticals LLC v. Novartis Pharmaceuticals Corp.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 18-2273 Document: 13 Page: 1 Filed: 04/23/2020 United States Court of Appeals for the Federal Circuit ______________________ ARGENTUM PHARMACEUTICALS LLC, Appellant v. NOVARTIS PHARMACEUTICALS CORPORATION, Appellee ______________________ 2018-2273 ______________________ Appeal from the United States Patent and Trademar…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.